We’re very grateful and honoured that our EP PerMed project DYNAMITE has secured funding.We’re very grateful and honoured to have received a grant of 4 600 000 NOK!

The grant will be used for studying the role of transcription factors in ovarian cancer relapse and chemoresistance using state-of-the-art methods for precision genomics!